
Reset all filters
01 2Tukysa
Main Therapeutic Indication : Oncology
Currency : USD
2023 Revenue in Millions : 17
2022 Revenue in Millions : 0
Growth (%) : Acquired from Seagen
Main Therapeutic Indication : Oncology
Currency : USD
2024 Revenue in Millions : 480
2023 Revenue in Millions : 18
Growth (%) : 2,567